[Use of rimantadine for the treatment and prevention of influenza in the polyclinic]. 1979

E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D009031 Moscow The capital of Russia.
D001952 Bridged-Ring Compounds Cyclic hydrocarbons that contain multiple rings which share one or more bridgehead connections. Bridged Compounds,Bridged Ring Compounds
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000218 Adamantane A tricyclo bridged hydrocarbon. Diamantane
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
November 1993, The Medical letter on drugs and therapeutics,
E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
September 1994, The Nurse practitioner,
E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
January 1988, La Revue de medecine interne,
E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
December 1989, Seminars in respiratory infections,
E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
January 1994, American journal of hospital pharmacy,
E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
February 1981, Klinicheskaia meditsina,
E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
September 1981, Antiviral research,
E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
January 1990, Presse medicale (Paris, France : 1983),
E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
January 1993, Duodecim; laaketieteellinen aikakauskirja,
E G Smagulova, and V F Krylov, and A A Alekseeva, and S A Demidova, and T P Kuptsevich
January 1999, PharmacoEconomics,
Copied contents to your clipboard!